Vrettos EI - Search Results

1

Design Principles Governing the Development of Theranostic Anticancer Agents and Their Nanoformulations with Photoacoustic Properties.

Kyrkou SG, Vrettos EI, Gorpas D, Crook T, Syed N, Tzakos AG. Kyrkou SG, et al. Among authors: vrettos ei. Pharmaceutics. 2022 Feb 4;14(2):362. doi: 10.3390/pharmaceutics14020362. Pharmaceutics. 2022. PMID: 35214094 Free PMC article. Review.

2

On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.

Vrettos EI, Mező G, Tzakos AG. Vrettos EI, et al. Beilstein J Org Chem. 2018 Apr 26;14:930-954. doi: 10.3762/bjoc.14.80. eCollection 2018. Beilstein J Org Chem. 2018. PMID: 29765474 Free PMC article. Review.

3

Construction of Peptide-Drug Conjugates for Selective Targeting of Malignant Tumor Cells.

Vrettos EI, Tzakos AG. Vrettos EI, et al. Methods Mol Biol. 2021;2207:327-338. doi: 10.1007/978-1-0716-0920-0_23. Methods Mol Biol. 2021. PMID: 33113145

4

Development of programmable gemcitabine-GnRH pro-drugs bearing linker controllable "click" oxime bond tethers and preclinical evaluation against prostate cancer.

Vrettos EI, Karampelas T, Sayyad N, Kougioumtzi A, Syed N, Crook T, Murphy C, Tamvakopoulos C, Tzakos AG. Vrettos EI, et al. Eur J Med Chem. 2021 Feb 5;211:113018. doi: 10.1016/j.ejmech.2020.113018. Epub 2020 Nov 12. Eur J Med Chem. 2021. PMID: 33223264

5

Enhancement of glioblastoma multiforme therapy through a novel Quercetin-Losartan hybrid.

Tsiailanis AD, Renziehausen A, Kiriakidi S, Vrettos EI, Markopoulos GS, Sayyad N, Hirmiz B, Aguilar MI, Del Borgo MP, Kolettas E, Widdop RE, Mavromoustakos T, Crook T, Syed N, Tzakos AG. Tsiailanis AD, et al. Among authors: vrettos ei. Free Radic Biol Med. 2020 Nov 20;160:391-402. doi: 10.1016/j.freeradbiomed.2020.08.007. Epub 2020 Aug 18. Free Radic Biol Med. 2020. PMID: 32822744

6

Single Peptide Backbone Surrogate Mutations to Regulate Angiotensin GPCR Subtype Selectivity.

Vrettos EI, Valverde IE, Mascarin A, Pallier PN, Cerofolini L, Fragai M, Parigi G, Hirmiz B, Bekas N, Grob NM, Stylos EΚ, Shaye H, Del Borgo M, Aguilar MI, Magnani F, Syed N, Crook T, Waqif E, Ghazaly E, Cherezov V, Widdop RE, Luchinat C, Michael-Titus AT, Mindt TL, Tzakos AG. Vrettos EI, et al. Chemistry. 2020 Aug 21;26(47):10690-10694. doi: 10.1002/chem.202000924. Epub 2020 Jul 21. Chemistry. 2020. PMID: 32691857

7

Development of a novel conjugatable sunitinib analogue validated through in vitro and in vivo preclinical settings.

El Mubarak MA, Leontari I, Efstathia G, Vrettos EI, Shaikh AK, Konstantinos SE, Danika C, Kalofonos HP, Tzakos AG, Sivolapenko GB. El Mubarak MA, et al. Among authors: vrettos ei. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Aug 15;1092:515-523. doi: 10.1016/j.jchromb.2018.05.050. Epub 2018 Jun 2. J Chromatogr B Analyt Technol Biomed Life Sci. 2018. PMID: 30008308

8

Development of bioactive gemcitabine-D-Lys⁶-GnRH prodrugs with linker-controllable drug release rate and enhanced biopharmaceutical profile.

Sayyad N, Vrettos EI, Karampelas T, Chatzigiannis CM, Spyridaki K, Liapakis G, Tamvakopoulos C, Tzakos AG. Sayyad N, et al. Among authors: vrettos ei. Eur J Med Chem. 2019 Mar 15;166:256-266. doi: 10.1016/j.ejmech.2019.01.041. Epub 2019 Jan 18. Eur J Med Chem. 2019. PMID: 30716713

9

Development of novel GnRH and Tat^48-60 based luminescent probes with enhanced cellular uptake and bioimaging profile.

Kougioumtzi A, Chatziathanasiadou MV, Vrettos EI, Sayyad N, Sakka M, Stathopoulos P, Mantzaris MD, Ganai AM, Karpoormath R, Vartholomatos G, Tsikaris V, Lazarides T, Murphy C, Tzakos AG. Kougioumtzi A, et al. Among authors: vrettos ei. Dalton Trans. 2021 Jul 6;50(26):9215-9224. doi: 10.1039/d1dt00060h. Dalton Trans. 2021. PMID: 34125130

10

Development of a DHA-Losartan hybrid as a potent inhibitor of multiple pathway-induced platelet aggregation.

Tsiailanis AD, Vrettos EI, Choleva M, Kiriakidi S, Ganai AM, Patha TK, Karpoormath R, Mavromoustakos T, Fragopoulou E, Tzakos AG. Tsiailanis AD, et al. Among authors: vrettos ei. J Biomol Struct Dyn. 2022;40(24):13889-13900. doi: 10.1080/07391102.2021.1996461. Epub 2021 Nov 18. J Biomol Struct Dyn. 2022. PMID: 34791990

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page